Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017
[Display omitted] We aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing three population-based studies conducted in three timepoints. We compared participants from IBERPOC conducted in 1997, EPISCAN conducted in 2...
Saved in:
Published in | Archivos de bronconeumología (English ed.) Vol. 59; no. 3; pp. 142 - 151 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Spain
Elsevier España, S.L.U
01.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | [Display omitted]
We aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing three population-based studies conducted in three timepoints.
We compared participants from IBERPOC conducted in 1997, EPISCAN conducted in 2007 and EPISCAN II in 2017. COPD was defined as a postbronchodilator FEV1/FVC (forced expiratory volume in 1s/forced vital capacity) ratio <0.70, according to GOLD criteria; subsequently, also as the FEV1/FVC below the lower limit of normal (LLN).
COPD prevalence in the population between 40 and 69 years decreased from 21.6% (95% CI 20.7%–23.2%) in 1997 to 8.8% (95% CI 8.2%–9.5%) in 2017, a 59.2% decline (p<0.001).
In 2007, the prevalence was 7.7% (95% CI 6.8%–8.7%) with an upward trend of 1.1 percentage points in 2017 (p=0.073). Overall COPD prevalence decreased in men and women, although a significant increase was observed in the last decade in females (p<0.05). Current smokers significantly increased in the last decades (25.4% in 1997, 29.1% in 2007 and 23.4% in 2017; p<0.001). Regrettably, COPD underdiagnosis was constantly high, 77.6% in 1997, 78.4% in 2007, and to 78.2% in 2017 (p=0.95), higher in younger ages (40–49 yrs and 50–59 yrs) and also higher in women than in men in all three studies (p<0.05).
We report a significant reduction of 59.2% in the prevalence of COPD in Spain from 1997 to 2017 in subjects aged 40–69 years. Our study highlights the significant underdiagnosis of COPD, particularly sustained in women and younger populations. |
---|---|
AbstractList | [Display omitted]
We aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing three population-based studies conducted in three timepoints.
We compared participants from IBERPOC conducted in 1997, EPISCAN conducted in 2007 and EPISCAN II in 2017. COPD was defined as a postbronchodilator FEV1/FVC (forced expiratory volume in 1s/forced vital capacity) ratio <0.70, according to GOLD criteria; subsequently, also as the FEV1/FVC below the lower limit of normal (LLN).
COPD prevalence in the population between 40 and 69 years decreased from 21.6% (95% CI 20.7%–23.2%) in 1997 to 8.8% (95% CI 8.2%–9.5%) in 2017, a 59.2% decline (p<0.001).
In 2007, the prevalence was 7.7% (95% CI 6.8%–8.7%) with an upward trend of 1.1 percentage points in 2017 (p=0.073). Overall COPD prevalence decreased in men and women, although a significant increase was observed in the last decade in females (p<0.05). Current smokers significantly increased in the last decades (25.4% in 1997, 29.1% in 2007 and 23.4% in 2017; p<0.001). Regrettably, COPD underdiagnosis was constantly high, 77.6% in 1997, 78.4% in 2007, and to 78.2% in 2017 (p=0.95), higher in younger ages (40–49 yrs and 50–59 yrs) and also higher in women than in men in all three studies (p<0.05).
We report a significant reduction of 59.2% in the prevalence of COPD in Spain from 1997 to 2017 in subjects aged 40–69 years. Our study highlights the significant underdiagnosis of COPD, particularly sustained in women and younger populations. Graphical abstract We aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing three population-based studies conducted in three timepoints.INTRODUCTIONWe aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing three population-based studies conducted in three timepoints.We compared participants from IBERPOC conducted in 1997, EPISCAN conducted in 2007 and EPISCAN II in 2017. COPD was defined as a postbronchodilator FEV1/FVC (forced expiratory volume in 1s/forced vital capacity) ratio <0.70, according to GOLD criteria; subsequently, also as the FEV1/FVC below the lower limit of normal (LLN).METHODSWe compared participants from IBERPOC conducted in 1997, EPISCAN conducted in 2007 and EPISCAN II in 2017. COPD was defined as a postbronchodilator FEV1/FVC (forced expiratory volume in 1s/forced vital capacity) ratio <0.70, according to GOLD criteria; subsequently, also as the FEV1/FVC below the lower limit of normal (LLN).COPD prevalence in the population between 40 and 69 years decreased from 21.6% (95% CI 20.7%-23.2%) in 1997 to 8.8% (95% CI 8.2%-9.5%) in 2017, a 59.2% decline (p<0.001). In 2007, the prevalence was 7.7% (95% CI 6.8%-8.7%) with an upward trend of 1.1 percentage points in 2017 (p=0.073). Overall COPD prevalence decreased in men and women, although a significant increase was observed in the last decade in females (p<0.05). Current smokers significantly increased in the last decades (25.4% in 1997, 29.1% in 2007 and 23.4% in 2017; p<0.001). Regrettably, COPD underdiagnosis was constantly high, 77.6% in 1997, 78.4% in 2007, and to 78.2% in 2017 (p=0.95), higher in younger ages (40-49 yrs and 50-59 yrs) and also higher in women than in men in all three studies (p<0.05).RESULTSCOPD prevalence in the population between 40 and 69 years decreased from 21.6% (95% CI 20.7%-23.2%) in 1997 to 8.8% (95% CI 8.2%-9.5%) in 2017, a 59.2% decline (p<0.001). In 2007, the prevalence was 7.7% (95% CI 6.8%-8.7%) with an upward trend of 1.1 percentage points in 2017 (p=0.073). Overall COPD prevalence decreased in men and women, although a significant increase was observed in the last decade in females (p<0.05). Current smokers significantly increased in the last decades (25.4% in 1997, 29.1% in 2007 and 23.4% in 2017; p<0.001). Regrettably, COPD underdiagnosis was constantly high, 77.6% in 1997, 78.4% in 2007, and to 78.2% in 2017 (p=0.95), higher in younger ages (40-49 yrs and 50-59 yrs) and also higher in women than in men in all three studies (p<0.05).We report a significant reduction of 59.2% in the prevalence of COPD in Spain from 1997 to 2017 in subjects aged 40-69 years. Our study highlights the significant underdiagnosis of COPD, particularly sustained in women and younger populations.CONCLUSIONSWe report a significant reduction of 59.2% in the prevalence of COPD in Spain from 1997 to 2017 in subjects aged 40-69 years. Our study highlights the significant underdiagnosis of COPD, particularly sustained in women and younger populations. We aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing three population-based studies conducted in three timepoints. We compared participants from IBERPOC conducted in 1997, EPISCAN conducted in 2007 and EPISCAN II in 2017. COPD was defined as a postbronchodilator FEV /FVC (forced expiratory volume in 1s/forced vital capacity) ratio <0.70, according to GOLD criteria; subsequently, also as the FEV /FVC below the lower limit of normal (LLN). COPD prevalence in the population between 40 and 69 years decreased from 21.6% (95% CI 20.7%-23.2%) in 1997 to 8.8% (95% CI 8.2%-9.5%) in 2017, a 59.2% decline (p<0.001). In 2007, the prevalence was 7.7% (95% CI 6.8%-8.7%) with an upward trend of 1.1 percentage points in 2017 (p=0.073). Overall COPD prevalence decreased in men and women, although a significant increase was observed in the last decade in females (p<0.05). Current smokers significantly increased in the last decades (25.4% in 1997, 29.1% in 2007 and 23.4% in 2017; p<0.001). Regrettably, COPD underdiagnosis was constantly high, 77.6% in 1997, 78.4% in 2007, and to 78.2% in 2017 (p=0.95), higher in younger ages (40-49 yrs and 50-59 yrs) and also higher in women than in men in all three studies (p<0.05). We report a significant reduction of 59.2% in the prevalence of COPD in Spain from 1997 to 2017 in subjects aged 40-69 years. Our study highlights the significant underdiagnosis of COPD, particularly sustained in women and younger populations. |
Author | Sánchez, Guadalupe Cosío, Borja G. García-Río, Francisco Casanova, Ciro Soriano, Joan B. Pérez González, Patricia Alfageme, Inmaculada Soler-Cataluña, Juan José García Castillo, Elena de Lucas, Pilar Miravitlles, Marc Peláez, Adrián Alonso Pérez, Tamara Rodríguez González-Moro, José Miguel Ancochea, Julio |
Author_xml | – sequence: 1 givenname: Elena surname: García Castillo fullname: García Castillo, Elena email: elenagcs@gmail.com organization: Pulmonary Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa, Madrid, Spain – sequence: 2 givenname: Tamara surname: Alonso Pérez fullname: Alonso Pérez, Tamara organization: Pulmonary Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa, Madrid, Spain – sequence: 3 givenname: Adrián surname: Peláez fullname: Peláez, Adrián organization: Pulmonary Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa, Madrid, Spain – sequence: 4 givenname: Patricia surname: Pérez González fullname: Pérez González, Patricia organization: Pulmonary Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa, Madrid, Spain – sequence: 5 givenname: Marc surname: Miravitlles fullname: Miravitlles, Marc organization: Pulmonary Department, Hospital Universitari Vall d’Hebron-CIBERES, Barcelona, Spain – sequence: 6 givenname: Inmaculada surname: Alfageme fullname: Alfageme, Inmaculada organization: Unidad de Gestión Clínica de Neumología, Hospital Universitario Virgen de Valme, Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain – sequence: 7 givenname: Ciro surname: Casanova fullname: Casanova, Ciro organization: Pulmonary Department-Research Unit, Hospital Universitario Nuestra Señora de Candelaria, CIBERES, ISCIII, Universidad de La Laguna, Tenerife, Spain – sequence: 8 givenname: Borja G. orcidid: 0000-0002-6388-8209 surname: Cosío fullname: Cosío, Borja G. organization: Pulmonary Department, Hospital Universitario Son Espases-IdISBa-Ciberes, Palma de Mallorca, Baleares, Spain – sequence: 9 givenname: Pilar surname: de Lucas fullname: de Lucas, Pilar organization: Pulmonary Department, Hospital General Gregorio Marañón, Madrid, Spain – sequence: 10 givenname: Francisco surname: García-Río fullname: García-Río, Francisco organization: Pulmonary Department, Hospital Universitario La Paz-IdiPAZ-CIBERES, Madrid, Spain – sequence: 11 givenname: José Miguel surname: Rodríguez González-Moro fullname: Rodríguez González-Moro, José Miguel organization: Pulmonary Department, Hospital Universitario de Alcalá de Henares, Madrid, Spain – sequence: 12 givenname: Juan José surname: Soler-Cataluña fullname: Soler-Cataluña, Juan José organization: Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain – sequence: 13 givenname: Guadalupe surname: Sánchez fullname: Sánchez, Guadalupe organization: Medical Department, GSK, Tres Cantos, Madrid, Spain – sequence: 14 givenname: Joan B. surname: Soriano fullname: Soriano, Joan B. organization: Pulmonary Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa, Madrid, Spain – sequence: 15 givenname: Julio surname: Ancochea fullname: Ancochea, Julio organization: Pulmonary Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa, Madrid, Spain |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36549937$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkk9v1DAQxS1URLeFb4CQjxxI8DhxHFcICVL-SZWKtMvZcpwJeMk6Wztptd8eR9tekFDFyXN471nvN3NGTvzokZCXwHJgUL3d5ia0AWPOGec5QM6gfEJWIKTKOHB1QlasYCzjtapOyVmMW8a4KEr-jJwWlSiVKuSKbDYBfRfp2NPm-vsldZ6u98b5C9r8Mv4nRvoRpztET5swxkjXaCc3ejPQ9Rxu8RApKCXfUM6YpMZ3aQD5nDztzRDxxf17Tn58_rRpvmZX11--NR-uMiugmrLCQN9zWbfcSCVVKsW6ui7rHrui71VpAArAwnaixRZFadMsjQBRc4Gir4pz8vqYuw_jzYxx0jsXLQ6D8TjOUXMpamBKVSpJX91L53aHnd4HtzPhoB9IJMHFUWCXngF7bd1klq5TMG7QwPSCXW_1EbtesGsAnbAnc_mX-SH_Edv7ow0TpFuHQUfr0FvsXEicdTe6_w2wg_POmuE3HjBuxzmkVUUNOnLN9Ho5iOUeeFpXVYFIAe_-HfD4_38Ah6nDDg |
CitedBy_id | crossref_primary_10_1016_j_arbres_2024_08_002 crossref_primary_10_1159_000539206 crossref_primary_10_1371_journal_pone_0291102 crossref_primary_10_3390_jcm13216367 crossref_primary_10_1097_MD_0000000000039901 crossref_primary_10_3390_jcm13237380 crossref_primary_10_1016_j_rmed_2023_107458 |
Cites_doi | 10.1378/chest.12-1135 10.1016/S2213-2600(20)30105-3 10.1016/j.arbres.2012.11.010 10.1183/09031936.00080312 10.1016/S0300-2896(15)30272-6 10.1378/chest.123.5.1684 10.1056/NEJMoa1411532 10.1183/09031936.05.00035205 10.1183/09031936.00178109 10.1183/16000617.0055-2018 10.1136/thx.2009.115725 10.1016/j.rmed.2018.03.020 10.1183/09031936.03.00075102 10.1186/s12940-019-0478-2 10.1183/09041950.005s1693 10.1016/S0140-6736(05)67632-5 10.1016/j.medcli.2018.05.011 10.2147/COPD.S377140 10.1016/S0140-6736(07)61377-4 10.1186/s12931-020-01536-4 10.1183/09031936.04.00014304 10.1164/ajrccm/136.5.1285 10.1136/thx.2008.098483 10.7189/jogh.05.020415 10.1183/09031936.05.00034805 10.1016/j.arbres.2013.04.001 10.1016/j.arbres.2016.10.008 10.1016/j.arbres.2018.05.011 10.1183/13993003.00610-2019 10.1183/09031936.00062907 10.1164/rccm.200703-456SO 10.1016/j.arbres.2020.01.025 10.1016/j.arbres.2008.06.001 10.1183/09031936.00138409 10.1016/j.arbres.2012.02.007 10.1183/09031936.95.08081398 10.1016/j.arbres.2020.07.024 10.1378/chest.14-2535 |
ContentType | Journal Article |
Copyright | 2022 SEPAR SEPAR Copyright © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. |
Copyright_xml | – notice: 2022 SEPAR – notice: SEPAR – notice: Copyright © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.arbres.2022.11.014 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Zoology |
EISSN | 1579-2129 |
EndPage | 151 |
ExternalDocumentID | 36549937 10_1016_j_arbres_2022_11_014 S0300289622006615 1_s2_0_S0300289622006615 |
Genre | Journal Article |
GeographicLocations | Spain |
GeographicLocations_xml | – name: Spain |
GroupedDBID | 0R~ 4.4 457 53G 65R AAEDT AALRI AAXUO AAYWO ABFNM ACGFS ACRLP ADBBV ADCUG ADVLN AEIPS AENEX AEVXI AFJKZ AFTJW AIGII AIKHN AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ASPBG AVWKF AZFZN BAWUL DIK E3Z F5P FDB FGOYB FIRID GX1 HZ~ O9- OK1 P2P P6G R2- ROL SES SPR T5K Z7D AACTN AFRHN AFXIZ BNPGV FRJ SSH Z5R AAYXX CITATION --K --M .1- .~1 1B1 1P~ 1~. 1~5 2WC 4G. 5VS 7-5 71M 8P~ AAEDW AAIKJ AAKOC AAOAW AAQFI ABBQC ABJNI ABMAC ABMZM ABXDB ACDAQ ADEZE AEBSH AEKER AFKWA AGHFR AGUBO AGYEJ AIEXJ AJOXV AJRQY AMFUW ANZVX AXJTR BKOJK BLXMC CGR CUY CVF ECM EFJIC EIF EO8 EO9 EP2 EP3 FEDTE FNPLU FYGXN G-Q GBLVA HVGLF IHE J1W KOM M41 MO0 N9A NPM O-L OAUVE OI- OU. OZT P-8 P-9 PC. Q38 RIG RPZ SDF SDG SPCBC SSZ ~G- 7X8 AAXKI ACIEU AGCQF AGRNS APXCP |
ID | FETCH-LOGICAL-c516t-3a1ff278b2a79790160d8848fed3ff94a1131e3cd5bebe54ce3c7a515825e5f63 |
IEDL.DBID | AIKHN |
ISSN | 0300-2896 1579-2129 |
IngestDate | Fri Jul 11 06:12:33 EDT 2025 Wed Feb 19 02:04:33 EST 2025 Tue Jul 01 01:10:54 EDT 2025 Thu Apr 24 23:08:20 EDT 2025 Fri Feb 23 02:37:08 EST 2024 Sun Feb 23 10:18:44 EST 2025 Tue Aug 26 18:38:08 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Spirometry Prevalence Underdiagnosis COPD Spain Smoking |
Language | English |
License | Copyright © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c516t-3a1ff278b2a79790160d8848fed3ff94a1131e3cd5bebe54ce3c7a515825e5f63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-6388-8209 |
OpenAccessLink | https://hdl.handle.net/10550/96976 |
PMID | 36549937 |
PQID | 2758109969 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2758109969 pubmed_primary_36549937 crossref_citationtrail_10_1016_j_arbres_2022_11_014 crossref_primary_10_1016_j_arbres_2022_11_014 elsevier_sciencedirect_doi_10_1016_j_arbres_2022_11_014 elsevier_clinicalkeyesjournals_1_s2_0_S0300289622006615 elsevier_clinicalkey_doi_10_1016_j_arbres_2022_11_014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-03-01 |
PublicationDateYYYYMMDD | 2023-03-01 |
PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Spain |
PublicationPlace_xml | – name: Spain |
PublicationTitle | Archivos de bronconeumología (English ed.) |
PublicationTitleAlternate | Arch Bronconeumol |
PublicationYear | 2023 |
Publisher | Elsevier España, S.L.U |
Publisher_xml | – name: Elsevier España, S.L.U |
References | Miller (bib0260) 2005; 26 Sobradillo, Miravitlles, Jiménez, Gabriel, Viejo, Masa (bib0225) 1999; 35 Izquierdo Alonso, De Lucas Ramos, Rodríguez González-Moro (bib0365) 2012; 48 García Castillo, Alonso Pérez, Peláez, Pérez González, Soriano, Ancochea (bib0380) 2022; 17 Lange, Celli, Agustí, Boje Jensen, Divo, Faner (bib0350) 2015; 373 Soriano, Alfageme, Miravitlles, de Lucas, Soler-Cataluña, García-Río (bib0240) 2021; 57 Lamprecht, Soriano, Studnicka, Kaiser, Vanfleteren, Gnatiuc (bib0385) 2015; 148 Menezes, Perez-Padilla, Jardim, Muiño, Lopez, Valdivia (bib0220) 2005; 366 Milanzi, Koppelman, Oldenwening, Augustijn, Aalders-de Ruijter, Farenhorst (bib0340) 2019; 18 Halbert, Isonaka, George, Iqbal (bib0305) 2003; 123 Blanco, Diego, Bueno, Casas-Maldonado, Miravitlles (bib0210) 2019; 54 Quanjer, Tammeling, Cotes, Pedersen, Peslin, Yernault (bib0275) 1993; 6 Adeloye, Chua, Lee, Basquill, Papana, Theodoratou (bib0335) 2015; 5 Roca, Sanchis, Agusti-Vidal, Segarra, Navajas, Rodriguez-Roisin (bib0270) 1986; 22 Dharmage, Erbas, Jarvis, Wjst, Raherison, Norback (bib0345) 2008; 33 Ancochea, Soriano (bib0395) 2021; 57 Gut-Gobert, Cavaillès, Dixmier, Guillot, Jouneau, Leroyer (bib0370) 2019; 28 Alonso, Sobradillo, de Torres (bib0390) 2017; 53 Rabe, Hurd, Anzueto, Barnes, Buist, Calverley (bib0285) 2007; 176 Bhatta, Leivseth, Mai, Chen, Henriksen, Langhammer (bib0315) 2018; 138 Swanney, Ruppel, Enright, Pedersen, Crapo, Miller (bib0290) 2008; 63 Pellegrino (bib0295) 2005; 26 Siafakas, Vermeire, Pride, Paoletti, Gibson, Howard (bib0230) 1995; 8 Quanjer, Stanojevic, Cole, Baur, Hall, Culver (bib0280) 2012; 40 García-Río, Calle, Burgos, Casan, del Campo, Galdiz (bib0265) 2013; 49 Ancochea, Badiola, Duran-Tauleria, Garcia Rio, Miravitlles, Muñoz (bib0245) 2009; 45 Soriano, Ancochea, Miravitlles, Garcia-Rio, Duran-Tauleria, Munoz (bib0310) 2010; 36 Vasankari, Impivaara, Heliövaara, Heistaro, Liippo, Puukka (bib0330) 2010; 36 . Soriano, Rojas-Rueda, Alonso, Antó, Cardona, Fernández (bib0375) 2018; 151 Soriano, Kendrick, Paulson, Gupta, Abrams, Adedoyin (bib0205) 2020; 8 Miravitlles, Soriano, Garcia-Rio, Munoz, Duran-Tauleria, Sanchez (bib0235) 2009; 64 Alfageme, de Lucas, Ancochea, Miravitlles, Soler-Cataluña, García-Río (bib0250) 2019; 55 Celli, MacNee, Agusti, Anzueto, Berg, Buist (bib0355) 2004; 23 Ford, Mannino, Wheaton, Giles, Presley-Cantrell, Croft (bib0325) 2013; 143 (bib0255) 1987; 136 Backman, Vanfleteren, Lindberg, Ekerljung, Stridsman, Axelsson (bib0320) 2020; 21 Buist, McBurnie, Vollmer, Gillespie, Burney, Mannino (bib0215) 2007; 370 Global strategy for prevention, diagnosis and management of COPD: 2022 Report. Celli, Halbert, Isonaka, Schau (bib0360) 2003; 22 Ancochea, Miravitlles, García-Río, Muñoz, Sánchez, Sobradillo (bib0400) 2013; 49 Quanjer (10.1016/j.arbres.2022.11.014_bib0280) 2012; 40 Soriano (10.1016/j.arbres.2022.11.014_bib0205) 2020; 8 Celli (10.1016/j.arbres.2022.11.014_bib0355) 2004; 23 Miller (10.1016/j.arbres.2022.11.014_bib0260) 2005; 26 García-Río (10.1016/j.arbres.2022.11.014_bib0265) 2013; 49 Rabe (10.1016/j.arbres.2022.11.014_bib0285) 2007; 176 Backman (10.1016/j.arbres.2022.11.014_bib0320) 2020; 21 (10.1016/j.arbres.2022.11.014_bib0255) 1987; 136 Bhatta (10.1016/j.arbres.2022.11.014_bib0315) 2018; 138 Menezes (10.1016/j.arbres.2022.11.014_bib0220) 2005; 366 Pellegrino (10.1016/j.arbres.2022.11.014_bib0295) 2005; 26 Milanzi (10.1016/j.arbres.2022.11.014_bib0340) 2019; 18 Ancochea (10.1016/j.arbres.2022.11.014_bib0395) 2021; 57 Ford (10.1016/j.arbres.2022.11.014_bib0325) 2013; 143 Quanjer (10.1016/j.arbres.2022.11.014_bib0275) 1993; 6 Swanney (10.1016/j.arbres.2022.11.014_bib0290) 2008; 63 10.1016/j.arbres.2022.11.014_bib0300 García Castillo (10.1016/j.arbres.2022.11.014_bib0380) 2022; 17 Lange (10.1016/j.arbres.2022.11.014_bib0350) 2015; 373 Adeloye (10.1016/j.arbres.2022.11.014_bib0335) 2015; 5 Gut-Gobert (10.1016/j.arbres.2022.11.014_bib0370) 2019; 28 Halbert (10.1016/j.arbres.2022.11.014_bib0305) 2003; 123 Lamprecht (10.1016/j.arbres.2022.11.014_bib0385) 2015; 148 Roca (10.1016/j.arbres.2022.11.014_bib0270) 1986; 22 Soriano (10.1016/j.arbres.2022.11.014_bib0310) 2010; 36 Dharmage (10.1016/j.arbres.2022.11.014_bib0345) 2008; 33 Alonso (10.1016/j.arbres.2022.11.014_bib0390) 2017; 53 Celli (10.1016/j.arbres.2022.11.014_bib0360) 2003; 22 Ancochea (10.1016/j.arbres.2022.11.014_bib0400) 2013; 49 Blanco (10.1016/j.arbres.2022.11.014_bib0210) 2019; 54 Vasankari (10.1016/j.arbres.2022.11.014_bib0330) 2010; 36 Izquierdo Alonso (10.1016/j.arbres.2022.11.014_bib0365) 2012; 48 Ancochea (10.1016/j.arbres.2022.11.014_bib0245) 2009; 45 Buist (10.1016/j.arbres.2022.11.014_bib0215) 2007; 370 Siafakas (10.1016/j.arbres.2022.11.014_bib0230) 1995; 8 Alfageme (10.1016/j.arbres.2022.11.014_bib0250) 2019; 55 Soriano (10.1016/j.arbres.2022.11.014_bib0375) 2018; 151 Soriano (10.1016/j.arbres.2022.11.014_bib0240) 2021; 57 Sobradillo (10.1016/j.arbres.2022.11.014_bib0225) 1999; 35 Miravitlles (10.1016/j.arbres.2022.11.014_bib0235) 2009; 64 |
References_xml | – volume: 21 start-page: 283 year: 2020 ident: bib0320 article-title: Decreased COPD prevalence in Sweden after decades of decrease in smoking publication-title: Respir Res – volume: 57 start-page: 61 year: 2021 end-page: 69 ident: bib0240 article-title: Prevalence and determinants of COPD in Spain: EPISCAN II publication-title: Arch Bronconeumol – volume: 48 start-page: 223 year: 2012 end-page: 228 ident: bib0365 article-title: El uso del límite inferior de la normalidad como criterio de EPOC excluye pacientes con elevada morbilidad y alto consumo de recursos sanitarios publication-title: Arch Bronconeumol – volume: 148 start-page: 971 year: 2015 end-page: 985 ident: bib0385 article-title: Determinants of underdiagnosis of COPD in National and International Surveys publication-title: Chest – volume: 8 start-page: 1398 year: 1995 end-page: 1420 ident: bib0230 article-title: Optimal assessment and management of chronic obstructive pulmonary disease (COPD) publication-title: Eur Respir J – volume: 53 start-page: 222 year: 2017 end-page: 227 ident: bib0390 article-title: Enfermedad pulmonar obstructiva crónica en mujeres: ¿somos diferentes? publication-title: Arch Bronconeumol – reference: Global strategy for prevention, diagnosis and management of COPD: 2022 Report. – volume: 36 start-page: 766 year: 2010 end-page: 773 ident: bib0330 article-title: No increase in the prevalence of COPD in two decades publication-title: Eur Respir J – volume: 23 start-page: 932 year: 2004 end-page: 946 ident: bib0355 article-title: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper publication-title: Eur Respir J – volume: 54 start-page: 1900610 year: 2019 ident: bib0210 article-title: Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps publication-title: Eur Respir J – volume: 63 start-page: 1046 year: 2008 end-page: 1051 ident: bib0290 article-title: Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction publication-title: Thorax – volume: 143 start-page: 1395 year: 2013 end-page: 1406 ident: bib0325 article-title: Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination Surveys from 1988–1994 to 2007–2010 publication-title: Chest – volume: 26 start-page: 948 year: 2005 end-page: 968 ident: bib0295 article-title: Interpretative strategies for lung function tests publication-title: Eur Respir J – volume: 123 start-page: 1684 year: 2003 end-page: 1692 ident: bib0305 article-title: Interpreting COPD prevalence estimates publication-title: Chest – volume: 55 start-page: 38 year: 2019 end-page: 47 ident: bib0250 article-title: 10 years after EPISCAN: a new study on the prevalence of COPD in Spain – a summary of the EPISCAN II protocol publication-title: Arch Bronconeumol – volume: 370 start-page: 741 year: 2007 end-page: 750 ident: bib0215 article-title: International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study publication-title: The Lancet – volume: 5 start-page: 020415 year: 2015 ident: bib0335 article-title: Global and regional estimates of COPD prevalence: systematic review and meta-analysis publication-title: J Glob Health – volume: 49 start-page: 223 year: 2013 end-page: 229 ident: bib0400 article-title: Infradiagnóstico de la enfermedad pulmonar obstructiva crónica en mujeres: cuantificación del problema, determinantes y propuestas de acción publication-title: Arch Bronconeumol – volume: 22 start-page: 268 year: 2003 end-page: 273 ident: bib0360 article-title: Population impact of different definitions of airway obstruction publication-title: Eur Respir J – volume: 22 start-page: 217 year: 1986 end-page: 224 ident: bib0270 article-title: Spirometric reference values from a Mediterranean population publication-title: Bull Eur Physiopathol Respir – volume: 36 start-page: 758 year: 2010 end-page: 765 ident: bib0310 article-title: Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007 publication-title: Eur Respir J – volume: 6 start-page: 5 year: 1993 end-page: 40 ident: bib0275 article-title: Lung volumes and forced ventilatory flows publication-title: Eur Respir J – volume: 366 start-page: 1875 year: 2005 end-page: 1881 ident: bib0220 article-title: Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study publication-title: The Lancet – volume: 64 start-page: 863 year: 2009 end-page: 868 ident: bib0235 article-title: Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities publication-title: Thorax – volume: 40 start-page: 1324 year: 2012 end-page: 1343 ident: bib0280 article-title: Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations publication-title: Eur Respir J – volume: 45 start-page: 41 year: 2009 end-page: 47 ident: bib0245 article-title: Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años en España publication-title: Arch Bronconeumol – volume: 373 start-page: 111 year: 2015 end-page: 122 ident: bib0350 article-title: Lung-function trajectories leading to chronic obstructive pulmonary disease publication-title: N Engl J Med – volume: 138 start-page: 50 year: 2018 end-page: 56 ident: bib0315 article-title: Prevalence and trend of COPD from 1995–1997 to 2006–2008: the HUNT study, Norway publication-title: Respir Med – reference: . – volume: 151 start-page: 171 year: 2018 end-page: 190 ident: bib0375 article-title: La carga de enfermedad en España: resultados del Estudio de la Carga Global de las Enfermedades 2016 publication-title: Med Clin (Barc) – volume: 176 start-page: 532 year: 2007 end-page: 555 ident: bib0285 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary publication-title: Am J Respir Crit Care Med – volume: 49 start-page: 388 year: 2013 end-page: 401 ident: bib0265 article-title: Espirometría publication-title: Arch Bronconeumol – volume: 8 start-page: 585 year: 2020 end-page: 596 ident: bib0205 article-title: Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet Respir Med – volume: 33 start-page: 237 year: 2008 end-page: 244 ident: bib0345 article-title: Do childhood respiratory infections continue to influence adult respiratory morbidity? publication-title: Eur Respir J – volume: 136 start-page: 1285 year: 1987 end-page: 1298 ident: bib0255 article-title: Standardization of spirometry – 1987 update publication-title: Am Rev Respir Dis – volume: 35 start-page: 159 year: 1999 end-page: 166 ident: bib0225 article-title: Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo publication-title: Arch Bronconeumol – volume: 28 start-page: 180055 year: 2019 ident: bib0370 article-title: Women and COPD: do we need more evidence? publication-title: Eur Respir Rev – volume: 57 start-page: 1 year: 2021 end-page: 2 ident: bib0395 article-title: La EPOC en España al inicio de una nueva década publication-title: Arch Bronconeumol – volume: 26 start-page: 319 year: 2005 end-page: 338 ident: bib0260 article-title: Standardisation of spirometry publication-title: Eur Respir J – volume: 18 start-page: 39 year: 2019 ident: bib0340 article-title: Considerations in the use of different spirometers in epidemiological studies publication-title: Environ Health – volume: 17 start-page: 2431 year: 2022 end-page: 2441 ident: bib0380 article-title: Prevalence of chronic obstructive pulmonary disease in an urban area. Changes in COPD ten years on publication-title: Int J COPD – volume: 143 start-page: 1395 year: 2013 ident: 10.1016/j.arbres.2022.11.014_bib0325 article-title: Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination Surveys from 1988–1994 to 2007–2010 publication-title: Chest doi: 10.1378/chest.12-1135 – volume: 8 start-page: 585 year: 2020 ident: 10.1016/j.arbres.2022.11.014_bib0205 article-title: Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30105-3 – volume: 49 start-page: 223 year: 2013 ident: 10.1016/j.arbres.2022.11.014_bib0400 article-title: Infradiagnóstico de la enfermedad pulmonar obstructiva crónica en mujeres: cuantificación del problema, determinantes y propuestas de acción publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2012.11.010 – volume: 40 start-page: 1324 year: 2012 ident: 10.1016/j.arbres.2022.11.014_bib0280 article-title: Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations publication-title: Eur Respir J doi: 10.1183/09031936.00080312 – volume: 35 start-page: 159 year: 1999 ident: 10.1016/j.arbres.2022.11.014_bib0225 article-title: Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo publication-title: Arch Bronconeumol doi: 10.1016/S0300-2896(15)30272-6 – volume: 123 start-page: 1684 year: 2003 ident: 10.1016/j.arbres.2022.11.014_bib0305 article-title: Interpreting COPD prevalence estimates publication-title: Chest doi: 10.1378/chest.123.5.1684 – volume: 373 start-page: 111 year: 2015 ident: 10.1016/j.arbres.2022.11.014_bib0350 article-title: Lung-function trajectories leading to chronic obstructive pulmonary disease publication-title: N Engl J Med doi: 10.1056/NEJMoa1411532 – volume: 26 start-page: 948 year: 2005 ident: 10.1016/j.arbres.2022.11.014_bib0295 article-title: Interpretative strategies for lung function tests publication-title: Eur Respir J doi: 10.1183/09031936.05.00035205 – volume: 36 start-page: 766 year: 2010 ident: 10.1016/j.arbres.2022.11.014_bib0330 article-title: No increase in the prevalence of COPD in two decades publication-title: Eur Respir J doi: 10.1183/09031936.00178109 – volume: 28 start-page: 180055 year: 2019 ident: 10.1016/j.arbres.2022.11.014_bib0370 article-title: Women and COPD: do we need more evidence? publication-title: Eur Respir Rev doi: 10.1183/16000617.0055-2018 – volume: 64 start-page: 863 year: 2009 ident: 10.1016/j.arbres.2022.11.014_bib0235 article-title: Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities publication-title: Thorax doi: 10.1136/thx.2009.115725 – volume: 138 start-page: 50 year: 2018 ident: 10.1016/j.arbres.2022.11.014_bib0315 article-title: Prevalence and trend of COPD from 1995–1997 to 2006–2008: the HUNT study, Norway publication-title: Respir Med doi: 10.1016/j.rmed.2018.03.020 – volume: 22 start-page: 268 year: 2003 ident: 10.1016/j.arbres.2022.11.014_bib0360 article-title: Population impact of different definitions of airway obstruction publication-title: Eur Respir J doi: 10.1183/09031936.03.00075102 – volume: 18 start-page: 39 year: 2019 ident: 10.1016/j.arbres.2022.11.014_bib0340 article-title: Considerations in the use of different spirometers in epidemiological studies publication-title: Environ Health doi: 10.1186/s12940-019-0478-2 – volume: 6 start-page: 5 issue: Suppl. 16 year: 1993 ident: 10.1016/j.arbres.2022.11.014_bib0275 article-title: Lung volumes and forced ventilatory flows publication-title: Eur Respir J doi: 10.1183/09041950.005s1693 – ident: 10.1016/j.arbres.2022.11.014_bib0300 – volume: 366 start-page: 1875 year: 2005 ident: 10.1016/j.arbres.2022.11.014_bib0220 article-title: Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study publication-title: The Lancet doi: 10.1016/S0140-6736(05)67632-5 – volume: 151 start-page: 171 year: 2018 ident: 10.1016/j.arbres.2022.11.014_bib0375 article-title: La carga de enfermedad en España: resultados del Estudio de la Carga Global de las Enfermedades 2016 publication-title: Med Clin (Barc) doi: 10.1016/j.medcli.2018.05.011 – volume: 17 start-page: 2431 year: 2022 ident: 10.1016/j.arbres.2022.11.014_bib0380 article-title: Prevalence of chronic obstructive pulmonary disease in an urban area. Changes in COPD ten years on publication-title: Int J COPD doi: 10.2147/COPD.S377140 – volume: 370 start-page: 741 year: 2007 ident: 10.1016/j.arbres.2022.11.014_bib0215 article-title: International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study publication-title: The Lancet doi: 10.1016/S0140-6736(07)61377-4 – volume: 21 start-page: 283 year: 2020 ident: 10.1016/j.arbres.2022.11.014_bib0320 article-title: Decreased COPD prevalence in Sweden after decades of decrease in smoking publication-title: Respir Res doi: 10.1186/s12931-020-01536-4 – volume: 23 start-page: 932 year: 2004 ident: 10.1016/j.arbres.2022.11.014_bib0355 article-title: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper publication-title: Eur Respir J doi: 10.1183/09031936.04.00014304 – volume: 136 start-page: 1285 year: 1987 ident: 10.1016/j.arbres.2022.11.014_bib0255 article-title: Standardization of spirometry – 1987 update publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/136.5.1285 – volume: 63 start-page: 1046 year: 2008 ident: 10.1016/j.arbres.2022.11.014_bib0290 article-title: Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction publication-title: Thorax doi: 10.1136/thx.2008.098483 – volume: 5 start-page: 020415 year: 2015 ident: 10.1016/j.arbres.2022.11.014_bib0335 article-title: Global and regional estimates of COPD prevalence: systematic review and meta-analysis publication-title: J Glob Health doi: 10.7189/jogh.05.020415 – volume: 26 start-page: 319 year: 2005 ident: 10.1016/j.arbres.2022.11.014_bib0260 article-title: Standardisation of spirometry publication-title: Eur Respir J doi: 10.1183/09031936.05.00034805 – volume: 49 start-page: 388 year: 2013 ident: 10.1016/j.arbres.2022.11.014_bib0265 article-title: Espirometría publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2013.04.001 – volume: 53 start-page: 222 year: 2017 ident: 10.1016/j.arbres.2022.11.014_bib0390 article-title: Enfermedad pulmonar obstructiva crónica en mujeres: ¿somos diferentes? publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2016.10.008 – volume: 55 start-page: 38 year: 2019 ident: 10.1016/j.arbres.2022.11.014_bib0250 article-title: 10 years after EPISCAN: a new study on the prevalence of COPD in Spain – a summary of the EPISCAN II protocol publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2018.05.011 – volume: 54 start-page: 1900610 year: 2019 ident: 10.1016/j.arbres.2022.11.014_bib0210 article-title: Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps publication-title: Eur Respir J doi: 10.1183/13993003.00610-2019 – volume: 33 start-page: 237 year: 2008 ident: 10.1016/j.arbres.2022.11.014_bib0345 article-title: Do childhood respiratory infections continue to influence adult respiratory morbidity? publication-title: Eur Respir J doi: 10.1183/09031936.00062907 – volume: 176 start-page: 532 year: 2007 ident: 10.1016/j.arbres.2022.11.014_bib0285 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200703-456SO – volume: 57 start-page: 1 year: 2021 ident: 10.1016/j.arbres.2022.11.014_bib0395 article-title: La EPOC en España al inicio de una nueva década publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2020.01.025 – volume: 22 start-page: 217 year: 1986 ident: 10.1016/j.arbres.2022.11.014_bib0270 article-title: Spirometric reference values from a Mediterranean population publication-title: Bull Eur Physiopathol Respir – volume: 45 start-page: 41 year: 2009 ident: 10.1016/j.arbres.2022.11.014_bib0245 article-title: Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años en España publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2008.06.001 – volume: 36 start-page: 758 year: 2010 ident: 10.1016/j.arbres.2022.11.014_bib0310 article-title: Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007 publication-title: Eur Respir J doi: 10.1183/09031936.00138409 – volume: 48 start-page: 223 year: 2012 ident: 10.1016/j.arbres.2022.11.014_bib0365 article-title: El uso del límite inferior de la normalidad como criterio de EPOC excluye pacientes con elevada morbilidad y alto consumo de recursos sanitarios publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2012.02.007 – volume: 8 start-page: 1398 year: 1995 ident: 10.1016/j.arbres.2022.11.014_bib0230 article-title: Optimal assessment and management of chronic obstructive pulmonary disease (COPD) publication-title: Eur Respir J doi: 10.1183/09031936.95.08081398 – volume: 57 start-page: 61 year: 2021 ident: 10.1016/j.arbres.2022.11.014_bib0240 article-title: Prevalence and determinants of COPD in Spain: EPISCAN II publication-title: Arch Bronconeumol doi: 10.1016/j.arbres.2020.07.024 – volume: 148 start-page: 971 year: 2015 ident: 10.1016/j.arbres.2022.11.014_bib0385 article-title: Determinants of underdiagnosis of COPD in National and International Surveys publication-title: Chest doi: 10.1378/chest.14-2535 |
SSID | ssj0025342 ssj0066111 |
Score | 2.3581462 |
Snippet | [Display omitted]
We aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing... Graphical abstract We aim to describe the changes in prevalence and risk factors associated to chronic obstructive pulmonary disease (COPD) in Spain, comparing three... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 142 |
SubjectTerms | COPD Cross-Sectional Studies Female Forced Expiratory Volume Humans Male Prevalence Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary/Respiratory Risk Factors Smoking Spain Spirometry Underdiagnosis Vital Capacity |
Title | Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017 |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0300289622006615 https://www.clinicalkey.es/playcontent/1-s2.0-S0300289622006615 https://dx.doi.org/10.1016/j.arbres.2022.11.014 https://www.ncbi.nlm.nih.gov/pubmed/36549937 https://www.proquest.com/docview/2758109969 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1dT9sw0GIgTXtBjH0VGPKkPS40jmM74Y2VsbIJNqkg9c1yYlvqhNKqHzzy27mLnWrTQEx7syNf7Jzvzne5DxPy0VhVGF-XScaNT3JQCJIqtXiJQKoMM156idnIF5dyeJ1_G4vxBhl0uTAYVhllf5DprbSOT_oRm_3ZZNIfAXmim0xmrf8AE823Ml5KIO2tk_Pvw8u13SV4Hp0JaYIAXQZdG-Zl5mB6Yt3uLDvCcp4sf-yEekwDbU-isx2yHVVIehJW-ZJsuGaXPL-ITvJX5CrEudKpp4MfP0_ppKGjmZk0xzSkEizo5xCcRQe4ADpqo7HwlaPV_BZ2lmJYyCeK_xepaSw0mHpNrs--XA2GSbw8IakFk8uEG-Z9pooqM6pUJRaSs0WRF95Z7n2ZG8Y4c7y2ooJ9FHkNbWVAuwGT0Qkv-Ruy2Uwb947QVBTAxTVTtuB5XVclZ9aljllUv0SleoR3CNN1rCyOF1zc6C6E7JcOaNaIZjA6NKC5R5I11CxU1nhivOj2QndZoyDnNIj-J-DUQ3BuEZl1oZleZDrVfxHU75B_0OQ_zPmhIxYN7Io-GNO46QoGgX2GzkhZ9sjbQEXrr-cSjXWu9v573n3yAno8xMgdkM3lfOXeg9K0rA7Js6M7dhhZA3pfx-weTwsR0g |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swELdQkdheJmAfdGzDk3gkaxzHcbI31g2Vj5ZJLRJvlhPbUqcprfrB389d7FSbADHtzUp8iXM-n-9yvzsTcqyNzLWriijh2kUpGARRGRs8RCCWmmmXuQyzkYejbHCTXtyK2y3Sb3NhEFYZdL_X6Y22Dld6gZu9-XTaG4N4YpgsS5r4ASaab2N1KtEh26fnl4PRxu8SPA3BhDhCgjaDroF56QW4nli3O0m-YDlPlj61Qz1lgTY70dkueRVMSHrqR7lHtmy9T3aGIUj-mkw8zpXOHO1f__xOpzUdz_W0_kp9KsGSfvPgLNrHAdBxg8bCR47XizuYWYqwkBOK_xeprg00mHxDbs5-TPqDKByeEFWCZauIa-ZcIvMy0bKQBRaSM3me5s4a7lyRasY4s7wyooR5FGkFbanBugGX0QqX8bekU89qe0BoLHJYxRWTJudpVZUFZ8bGlhk0v0Qpu4S3DFNVqCyOB1z8Vi2E7JfybFbIZnA6FLC5S6IN1dxX1nimv2jnQrVZo6DnFKj-Z-jkY3R2GRbrUjG1TFSsHgjUn5R_yeQ_vPNzKywKlivGYHRtZ2voBP4ZBiOzokveeSnafD3P0Fnn8v1_v_eIvBhMhlfq6nx0eUhewh3u8XIfSGe1WNuPYECtyk9hgdwDWQESyQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+of+COPD+in+Spain%3A+Changes+Between+Cross+Sectional+Surveys+1997%2C+2007+and+2017&rft.jtitle=Archivos+de+bronconeumolog%C3%ADa&rft.au=Garc%C3%ADa+Castillo%2C+Elena&rft.au=Alonso+P%C3%A9rez%2C+Tamara&rft.au=Pel%C3%A1ez%2C+Adri%C3%A1n&rft.au=P%C3%A9rez+Gonz%C3%A1lez%2C+Patricia&rft.date=2023-03-01&rft.issn=0300-2896&rft.volume=59&rft.issue=3&rft.spage=142&rft.epage=151&rft_id=info:doi/10.1016%2Fj.arbres.2022.11.014&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_arbres_2022_11_014 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03002896%2FS0300289622X00148%2Fcov150h.gif |